Medicure (MCUJF) Stock Price, News & Analysis

Company Overview

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.

Key Stats

• Today's Range: $0.83 to $0.83
• 50-Day Range: $0.44 to $0.86
• 52-Week Range: $0.44 to $0.92
• Volume: 100 shs
• Average Volume: 3,433 shs
• Market Capitalization: $8.66 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MCUJF Stock Analysis - Frequently Asked Questions

How have MCUJF shares performed this year?

Medicure's stock was trading at $0.62 at the start of the year. Since then, MCUJF shares have increased by 33.9% and is now trading at $0.8299.
View the best growth stocks for 2025 here.

How were Medicure's earnings last quarter?

Medicure Inc. (OTCMKTS:MCUJF) posted its quarterly earnings results on Wednesday, May, 21st. The company reported ($0.05) EPS for the quarter. The firm had revenue of $3.82 million for the quarter. Medicure had a negative net margin of 9.62% and a negative trailing twelve-month return on equity of 10.12%.

How do I buy shares of Medicure?

Shares of MCUJF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 5/21/2025
• Today: 6/14/2025
• Next Earnings (Estimated): 8/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MCUJF
• CIK: 1133519
• Web: www.medicure.com
• Phone: (204) 487-7412
• Fax: 204-488-9823
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.13)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$680 thousand
• Net Margins: -9.62%
• Pretax Margin: -9.24%
• Return on Equity: -10.12%
• Return on Assets: -7.13%

Debt

• Debt-to-Equity Ratio: 0.03
• Current Ratio: 2.03
• Quick Ratio: 1.64

Sales & Book Value

• Annual Sales: $16.07 million
• Price / Sales: 0.54
• Cash Flow: $0.14 per share
• Price / Cash Flow: 5.92
• Book Value: $1.41 per share
• Price / Book: 0.59

Miscellaneous

• Outstanding Shares: 10,436,000
• Free Float: 9,090,000
• Market Cap: $8.66 million
• Optionable: Not Optionable
• Beta: 1.03